Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

FFA's causes may include environmental triggers and genetic factors.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

People with lichen planus have higher bad cholesterol and lower good cholesterol, increasing their risk for heart disease.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Some men lost hair after deoxycholic acid treatment for neck fat, but most saw improvement or resolution.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Saw palmetto causes allergic reaction, minoxidil causes skin irritation; use cautiously for hair loss.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

Pigmented casts are common in several hair loss conditions and can help diagnose specific types of alopecia.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.